CI, you are right! The share price will be much,

CI, you are right! The share price will be much, much higher b4 Leronlimab is approved especially with the cancer applications so I still say we will hit 33/share on the Nasdaq. The revenue is one thing and that will be later but with the success of the trials including TNBC, the share price will fly like I said above. Nice to see you here & GLTU

HCIT

https://media.gettyimages.com/photos/the-grea...wdoE_swYM=